| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.85B | — | +20.1% |
| Cost of Revenue | $364.5M | — | +24.4% |
| Gross Profit | $1.49B | — | +19.1% |
| R&D Expense | $214.0M | — | +7.8% |
| SG&A Expense | $56.2M | — | -2.8% |
| Operating Income | $580.0M | — | +27.8% |
| Pre-tax Income | $656.6M | — | +26.4% |
| Income Tax | $122.0M | — | +26.4% |
| Net Income | $534.5M | — | +23.3% |
| EPS (Basic) | $0.72 | — | +28.6% |
| EPS (Diluted) | $0.72 | — | +28.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.22B | -10.9% | -38.2% |
| Accounts Receivable | $1.49B | -12.1% | +26.6% |
| Inventory | $369.6M | -7.5% | +1.9% |
| Current Assets | $5.33B | -9.6% | -17.2% |
| Total Assets | $9.88B | -4.9% | -5.0% |
| Current Liabilities | $4.62B | -8.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.08B | — | +24.8% |
| Capital Expenditures | $70.6M | — | +6.2% |
| Investing Cash Flow | -$5.7M | — | +94.9% |
| Financing Cash Flow | -$1.34B | — | -4006.7% |
| Free Cash Flow | $1.01B | — | +26.3% |
| -2.2% |
| Long-term Debt | $496.8M | +0.0% | +0.1% |
| Total Liabilities | $8.89B | -2.8% | +5.3% |
| Stockholders' Equity | $989.7M | -20.0% | -49.6% |